Canada vs Tajikistan: Antiretroviral therapy coverage for PMTCT
Canada
92.0%
in 2009
Tajikistan
92.0%
in 2024
Canada rank
22nd
Tajikistan rank
22nd
Antiretroviral therapy coverage for PMTCT over time
- Canada
- Tajikistan
How they compare
Canada currently reports 92.0% against 92.0% in Tajikistan, a difference of 0.0%.
Across all 10 years both countries report, Canada has been ahead every year.
Canada ranks 22nd and Tajikistan ranks 22nd of 84 countries.
Canada has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Canada or Tajikistan?
- Canada, at 92.0% against 92.0% in Tajikistan as of 2009.
- What is the difference in antiretroviral therapy coverage for pmtct between Canada and Tajikistan?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Tajikistan?
- 10 years are reported by both, from 2000 to 2009.
- How do Canada and Tajikistan rank globally for antiretroviral therapy coverage for pmtct?
- Canada ranks 22nd and Tajikistan ranks 22nd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).